U.S. Regulators Want Safety Data from Vaginal Mesh Manufacturers
The United States Food and Drug Administration wrote to 33 vaginal mesh manufacturers, including Johnson & Johnson and C.R. Bard, requesting more safety and effectiveness data over a three-year period.
(EMAILWIRE.COM, February 06, 2012 ) Pittsburgh, PA -- Responding to patient advocates' concern over the safety and effectiveness of vaginal mesh, United States regulators are requesting that Johnson & Johnson, C.R. Bard, Inc., and 31 other vaginal mesh manufacturers provide data on the safety and effectiveness of its products.
This comes to light after nearly 650 lawsuits have been filed by women across the country claiming that vaginal mesh has harmed them. Additionally, there has been heightened scrutiny about the process that the U.S. Food and Drug Administration (FDA) used to clear the device for patient use without prior research or testing.
The FDA wrote a letter to these manufacturers requesting an additional three years of clinical trials to test the safety and effectiveness of the device. A report issued by the agency in July 2011 found a fivefold jump in injuries, malfunctions, and even deaths associated with the device.
The letters ask manufacturers to collect data and results about potential complications of transvaginal mesh. In July, the FDA said that it did not have enough data to warrant an official recall of the device.
In 2010, almost 300,000 synthetic meshes were implanted in women to treat pelvic organ prolapse (POP) or stress urinary incontinence (SUI), the agency estimates.
Amy Allina, a policy director at the National Women's Health Network in Washington, said that these letters will only affect products already on the market, but she would like the action to be just a first step toward requiring studies to be done before products reach patients.
The FDA first began warning about vaginal mesh in 2008 when it asked physicians, surgeons and other health care professionals to warn patients of any complications the agency deemed were serious, but rare. The agency also asked surgeons to receive specialized training on how to properly implant the device.
Vaginal mesh products were approved by the FDA's 501(k) system, where devices may be approved for patient use if manufacturers can show that their device is similar to those already on the market, which means newly manufactured products will not require testing or trials prior to approval. However, once a device is developed and is approved through other means by the FDA, all other devices that follow can be approved without human testing even if the original device is faulty and causes complications in patients.
This is what happened with the vaginal mesh devices that Johnson & Johnson, C.R. Bard, Inc., and other manufacturers made. These devices were approved through the 501(k) system even after the original device was shown to hurt women.
If you or someone you love has been adversely affected by a vaginal mesh implant, contact http://www.legalview.com/ to receive a free legal consultation from one of our experienced personal injury lawyers.
About LegalView:
LegalView is a public service brought to you by Legal WebTV Network, LLC, a Limited Liability Corporation created by a group of the nation's most highly respected law firms: Anapol Schwartz; Cohen, Placitella and Roth; James F. Humphreys and Associates; and Lopez McHugh. For more information on the accomplishments and track records of LegalView's superior sponsoring law firms and to get in touch with LegalView attorneys, visit LegalView at www.Legalview.com.
This comes to light after nearly 650 lawsuits have been filed by women across the country claiming that vaginal mesh has harmed them. Additionally, there has been heightened scrutiny about the process that the U.S. Food and Drug Administration (FDA) used to clear the device for patient use without prior research or testing.
The FDA wrote a letter to these manufacturers requesting an additional three years of clinical trials to test the safety and effectiveness of the device. A report issued by the agency in July 2011 found a fivefold jump in injuries, malfunctions, and even deaths associated with the device.
The letters ask manufacturers to collect data and results about potential complications of transvaginal mesh. In July, the FDA said that it did not have enough data to warrant an official recall of the device.
In 2010, almost 300,000 synthetic meshes were implanted in women to treat pelvic organ prolapse (POP) or stress urinary incontinence (SUI), the agency estimates.
Amy Allina, a policy director at the National Women's Health Network in Washington, said that these letters will only affect products already on the market, but she would like the action to be just a first step toward requiring studies to be done before products reach patients.
The FDA first began warning about vaginal mesh in 2008 when it asked physicians, surgeons and other health care professionals to warn patients of any complications the agency deemed were serious, but rare. The agency also asked surgeons to receive specialized training on how to properly implant the device.
Vaginal mesh products were approved by the FDA's 501(k) system, where devices may be approved for patient use if manufacturers can show that their device is similar to those already on the market, which means newly manufactured products will not require testing or trials prior to approval. However, once a device is developed and is approved through other means by the FDA, all other devices that follow can be approved without human testing even if the original device is faulty and causes complications in patients.
This is what happened with the vaginal mesh devices that Johnson & Johnson, C.R. Bard, Inc., and other manufacturers made. These devices were approved through the 501(k) system even after the original device was shown to hurt women.
If you or someone you love has been adversely affected by a vaginal mesh implant, contact http://www.legalview.com/ to receive a free legal consultation from one of our experienced personal injury lawyers.
About LegalView:
LegalView is a public service brought to you by Legal WebTV Network, LLC, a Limited Liability Corporation created by a group of the nation's most highly respected law firms: Anapol Schwartz; Cohen, Placitella and Roth; James F. Humphreys and Associates; and Lopez McHugh. For more information on the accomplishments and track records of LegalView's superior sponsoring law firms and to get in touch with LegalView attorneys, visit LegalView at www.Legalview.com.
Contact Information:
LegalView
Danielle Franklin
Tel: 9702168847
Email us
This is a press release. Press release distribution and press release services by EmailWire.Com: http://www.emailwire.com/us-press-release-distribution.php.
LegalView
Danielle Franklin
Tel: 9702168847
Email us
This is a press release. Press release distribution and press release services by EmailWire.Com: http://www.emailwire.com/us-press-release-distribution.php.
|
Private Equity, Angel Investing
Equity Alliance / Private Equity, Angel Investing, / IPO, Venture Capital & IR services / Equity Alliance International Equityallianceir.com Penny Stocks to Watch Sign up for hot penny stock picks Gains of 500%+ possible! Premiumstockpicks.com/landing/ Satellite TV for PC Watch Streaming Tv Right on Your PC Satellitetelevisionforpc.com Your text Ads & PR Text Ads plus unlimited press releases, One release featured/Day for only $575 per month. Read more on Text Ads & PR Your text Ads Here! Text Ads are only $289 per month. Ads are placed same day. More on Text Ads Advertising |